Attovia Therapeutics Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
ATTO•Second-quarter financial results and corporate update
Sept. 2 (Reuters) - Attovia Therapeutics Inc. ATTO.O:
- Attovia Therapeutics reports second quarter 2026 financial results and provides a corporate update
- Attovia Therapeutics - Q2 collaboration revenue was $0.50 million
- Attovia Therapeutics - Q2 net loss was $20.70 million
